Quantitation of meperidine hydrochloride in pharmaceutical dosage forms by high-performance liquid chromatography.
A high-performance liquid chromatographic (HPLC) method for the quantitative determination of meperidine hydrochloride in pharmaceutical dosage forms was developed. The method is reproducible and precise with relative standard deviations (based on six readings) of 1.2% with hydroxyzine and 0.93% with hydroxyprogesterone caproate as the internal standards. A variety of other active and inactive ingredients which were mixed with meperidine hydrochloride did not interfere with the assay procedure. Among the ingredients tested were acetaminophen, atropine sulfate, disodium edetate, metacresol, phenol, promethazine, and sodium metabisulfite. This method appears to be stability-indicating since a hydrolyzed sample of meperidine showed zero potency and a new peak with a different retention time.
D000077713:17 alpha-Hydroxyprogesterone Caproate; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D006908:Hydroxyprogesterones / Q000032:analysis; D008614:Meperidine / Q000032:analysis*; D012996:Solutions / Q000032:analysis; D013607:Tablets / Q000032:analysis
D006908:Hydroxyprogesterones; D012996:Solutions; D013607:Tablets; D000077713:17 alpha-Hydroxyprogesterone Caproate; D008614:Meperidine